Bliss GVS Pharma Ltd (BLISSGVS)


📊 End of Day Bhavcopy

Date: 2025-09-09

Price: 154.00
% Change: -0.50% (Prev Close: 154.77)

Volume: 1,92,548
% Change: -24.38% (Prev Volume: 2,54,639)

Delivery: 74,865
Delivery % : 38.88
% Change: -42.69% (Prev Delivery: 1,30,643)

Turnover: 296 Lacs
% Change: -24.68% (Prev Turnover: 393)

💹 EOD Valuation

P/E Ratio: 15.22
P/B Ratio: 1.54
Market Cap: 1625 Rs. Cr.



Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: BLISSGVS
Market Cap: 1643 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 190.97
52 Week Low: 105.05

All-Time High: 230.00 Rs.
All-Time Low: 0.95 Rs.


Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-11.42% | 16.25% | 27.10% | 24.18% | 25.07%


👥 Shareholding Pattern

Promoter Holding

Promoter Holding: 35.44%

Change (3Y | 1Y): 0.93% | 0.15%

Pledged %: 0.00%

FII Holding

FII Holding: 12.65%

Change (3Y | 1Y): -4.52% | -0.53%

DII Holding

DII Holding: 6.54%

Change (3Y | 1Y): -0.11% | -0.01%

Public Holding: 45.37%


🏦 Financial Strength

Debt to Equity: 0.08
Debt: 88.10 Rs. Cr.

Book Value: 99.68 Rs.
Current Ratio: 4.81
Interest Coverage: 14.16
Free Cash Flow: 33.03 Rs. Cr.


📈 Growth & Sales

Sales Growth: 4.93%

Sales Growth Qtr (YOY | QoQ):
12.98% | 4.79%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
3.27% | 2.70% | 4.93%


💰 Profit & Earnings

Profit Growth %

Profit Growth: 4.31%

Profit Growth Qtr (YOY | QoQ):
107.92% | 166.43%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-4.53% | 43.88% | 4.31%


EPS Rs.

EPS (TTM): 10.12 Rs.

EPS Qtr (Last Year | Latest):
1.97 Rs. | 4.08 Rs.

EPS Annual (Last Annual | Annual March):
7.21 Rs. | 8.00 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-4.93% | 43.10%


Net Profit Rs. Cr.

Net Profit (TTM): 112.50 Rs. Cr.

Net Profit (Annual - March): 90.26 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
22.11| 16.65 | 44.36


EBITDA Rs. Cr.

EBITDA (Quarter): 76.78 Rs. Cr.
EBITDA (Previous Yr Ql): 38.45 Rs. Cr.

EBITDA (Annual - March): 163.18 Rs. Cr.
EBITDA (Previous Annual): 179.07 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
0.18% | 2.90%


📊 Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 16.04%

OPM Qtr (Previous | Current):
10.65% | 19.92%

OPM Annual (5 Yrs | Last Yr | March):
16.95% | 19.55% | 15.65%


Return on Equity %

ROE: 8.36%

ROE (5 Yrs | 3 Yrs | Last Yr):
7.92% | 8.95% | 10.19%


Return on Capital Employed %

ROCE: 11.72%

ROCE (5 Yrs | 3 Yrs | Last Yr):
12.75% | 12.62% | 14.39%


Return on Assets %

ROA (TTM): 7.19%

ROA (5 Yrs | 3 Yrs | Last Yr):
6.71% | 7.52% | 8.61%



PEG Ratio: 0.35
Dividend Yield: 0.32%

PE 3 Yrs: 13.82
PE 5 Yrs: 14.69

Dividend Yield: 0.32%


👥 Company

Bliss GVS Pharma Ltd

BLISSGVS

Promoter Holding: %